To our knowledge, this is the first study to provide evidence that genetic variations of BCL2 may play an important role in predicting the susceptibility of lung cancer and overall survival of advanced NSCLC patients in male Chinese. Here, BCL2 is linked to non-small cell lung carcinoma.